Skip Navigation

AIDSInfo-at-a-glance

Issue No. 5 | February 07, 2013
A Service of the U.S. Department of Health and Human ServicesView HTML version
News and Features 

February 7 is National Black HIV/AIDS Awareness Day

AIDSinfo joins individuals and organizations across the nation in observing National Black HIV/AIDS Awareness Day. The awareness day is set aside each year to acknowledge the disproportionate burden of HIV/AIDS in the African-American community. In 2009, according to CDC, African Americans represented 14% of the U.S. population but accounted for 44% of all new HIV infections.

To learn more about HIV/AIDS and African Americans, please explore our National Black HIV/AIDS Awareness Day webpage [en español].

Explore the Updated AIDSinfo and infoSIDA Mobile Sites

Check out our updated AIDSinfo and infoSIDA mobile sites!
 
Updates include the following:

  • New design that evokes the look and feel of an app
  • Reorganized content to match the display on the redesigned AIDSinfo and infoSIDA websites
  • Improved navigation to make information easier to access
  • Addition of the news section and e-newsletter sign-up page
  • Improved access to Facebook and Twitter links
  • Addition of a home page image slideshow to highlight new and updated website content
  • Improved search engine optimization (SEO) to make it easier for Google and other search engines to index content on the sites

We will continue to update our mobile sites to meet the increasing demand for on-the-go access to HIV/AIDS-related information.
 
Please send your comments on the mobile sites to ContactUs@aidsinfo.nih.gov.

FDA Updates Darunavir Tablet and Oral Suspension Labeling with Pediatric Dosing Information

“On February 1, 2013, FDA approved revisions to the Prezista (darunavir) tablet and oral suspension label to include once daily dosing in treatment-naïve subjects 3 to less than 18 years of age and once daily dosing in treatment-experienced subjects 3 to less than 18 years of age with no darunavir resistance associated substitutions.”

The updated labeling will be available at the FDA website.

More information is available:

Home | Guidelines | Clinical Trials | Drugs | Health Topics | Education Materials | Mobile Resources & Tools
Unsubscribe | Contact Us
Left footer corner image Left footer corner image